Published date: 12 March 2020
This notice was replaced on 15 September 2020
This notice does not contain the most up-to-date information about this procurement. The most recent notice is:
Awarded contract (published 15 September 2020)
Closed opportunity - This means that the contract is currently closed. The buying department may be considering suppliers that have already applied, or no suitable offers were made.
Contract summary
Industry
Pharmaceutical products - 33600000
Location of contract
North East, North West, Yorkshire and the Humber, East Midlands, West Midlands, East of England, London, South East, South West
Value of contract
£301,101,314 to £602,202,628
Procurement reference
tender_232387/834760
Published date
12 March 2020
Closing date
15 April 2020
Contract start date
1 September 2020
Contract end date
31 August 2022
Contract type
Supply contract
Procedure type
Open procedure (above threshold)
Any interested supplier may submit a tender in response to an opportunity notice.
This procedure can be used for procurements above the relevant contract value threshold.
Contract is suitable for SMEs?
Yes
Contract is suitable for VCSEs?
No
Description
NHS Framework for the NHS London Region, Branded Medicines - Tranche A, Annual Tranche - Cytokine Modulators and other products, and Dolutegravir / Lamivudine
Offer reference number: CM/PHR/16/5516
CM/PHR/16/5516/01 - London Tranche A - 1 September 2020 to 31 August 2022 with an option to extend (at the Authority's discretion) for a period or periods up to a total of 24 months
CM/PHR/16/5516/02 - London Annual Tranche - Cytokine Modulators and other products - 1 September 2020 to 31 August 2021 with an option to extend (at the Authority's discretion) for a period or periods up to a total of 12 months
CM/PHR/16/5516/03 - NHS Framework agreement for the supply of Dolutegravir / Lamivudine - North of England - 1 September 2020 - 28 February 2021, South of England - 1 September 2020 - 31 August 2021, Midlands & East - 1 September 2020 - 28 February 2022, all with an option to extend (at the Authority's discretion) for a period or periods up to a total of 24 months
More information
Attachments
-
- 2020-OJS051-122254-en.pdf
- Tender notice
- n/a
-
- Document No. 01 - Invitation to offer covering letter.DOC
- Tender notice
- n/a
-
- Document No. 02 - Terms of offer.doc
- Tender notice
- n/a
-
- Document No. 03 - Framework Agreement and Terms and Conditions.docx
- Tender notice
- n/a
-
- Document No. 04 - Contract technical specification.doc
- Tender notice
- n/a
-
- Document No. 05 - Selectt offer schedule instructions.DOC
- Tender notice
- n/a
-
- Document No. 05a(i) Select Offer Schedule -CM_PHR_16_5516_01.xml
- Tender notice
- n/a
-
- Document No. 05a(ii) Select Offer Schedule -CM_PHR_16_5516_02.xml
- Tender notice
- n/a
-
- Document No. 05a(iii) Select Offer Schedule -CM_PHR_16_5516_03.xml
- Tender notice
- n/a
-
- Document No. 05c - Offer Schedule CM_PHR_16_5516_01&02&03.xls
- Tender notice
- n/a
-
- Document No. 06 - Form of offer.doc
- Tender notice
- n/a
-
- Document No. 07a - Quality control technical sheet.doc
- Tender notice
- n/a
-
- Document No. 08 - Confidential information schedule.XLS
- Tender notice
- n/a
-
- Document No. 09 - Tender Design and Instructions on completing.doc
- Tender notice
- n/a
-
- Qualification Questionnaire .xlsx
- Tender notice
- n/a
Share this notice
All content is available under the
